Metabolism of oral glucose in pancreas transplant recipients with normal and impaired glucose tolerance

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 7, 1997, Pages 2299-2307

  Christiansen, E ^a   Tibell, A ^b   Volund A A ^c   Holst, J J ^d   Rasmussen, K ^e   Schaffer, L ^c   Madsbad, S ^e  

^a STENO DIABETES CENTER   (Denmark)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c NOVO NORDISK A S   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; KINETICS; LIPID METABOLISM; MALE; PANCREAS TRANSPLANTATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0030743448     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.7.2299     Document Type: Article

References (38)

1. Elahi D, Clark BA, McAloon-Dyke M, et al. 1991 Islet cell responses to glucose in human transplanted pancreas. Am J Physiol. 261:E800-E808.
2. Blackman JD, Polonsky KS, Jaspan JB, et al. 1992 Insulin secretory profiles and C-peptide clearance kinetics at 6 months and 2 years after kidney-pancreas transplantation. Diabetes. 41:1346-1354.
3. Christiansen E, Andersen HB, Rasmussen K, et al. 1993 Pancreatic β-cell function and glucose metabolism in human pancreas and kidney transplantation. Am J Physiol. 264:E441-E449.
4. Christiansen E, Tibell A, Madsbad S, et al. 1993 Defects in quantitative and qualitative β-cell function following successful segmental pancreas transplantation. Transplant Proc. 25:1186-1189.
5. Katz H, Homan M, Velosa J, et al. 1991 Effects of pancreas transplantation on postprandial glucose metabolism. N Engl J Med. 325:1278-1283.
6. Diem P, Abid M, Redmon JB, et al. 1990 Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type 1 diabetic recipients. Diabetes. 39:534-540.
7. Luzi L, Secchi A, Facchini F, et al. 1990 Reduction of insulin resistance by combined kidney-pancreas transplantation in type 1 (insulin-dependent) diabetic patients. Diabetologia. 33:549-556.
8. Pfeffer F, Nauck MA, Benz S, et al. 1996 Determinants of a normal (versus impaired) oral glucose tolerance after combined pancreas-kidney transplantation in IDDM. Diabetologia. 39:462-468.
9. Christiansen E, Vestergaard H, Tibell A, et al. 1996 Impaired insulin-stimulated non-oxidative glucose metabolism in pancreas-kidney transplant recipients, dose-response characteristics of insulin on glucose turnover. Diabetes. 45:1267-1275.
10. Stumvoll M, Chintalapudi U, Perriello G, Welle, Gutierrez O, Gerich J. 1995 Uptake and release of glucose by the human kidney. J Clin Invest. 96:2528-2533.
11. WHO Expert Committee on Diabetes Mellitus. 1980 Second report. WHO Tech Rep Ser 646; 1-80.
12. Bergman RN. 1989 Toward physiological understanding of glucose tolerance. Minimal model approach. Diabetes. 38:1512-1527.
13. Christiansen E, Tibell A, Vølund Aa, et al. 1994 Insulin secretion, insulin action and non-insulin-dependent glucose uptake in pancreas transplant recipients. J Clin Endocrinol Metab. 79:1561-1569.
14. Quon M, Cochran C, Taylor SI, Eastman RC. 1994 Non-insulin-mediated glucose disappearance in subjects with IDDM. Discordance between experimental results and minimal model analysis. Diabetes. 43:890-896.
15. Saad MF, Anderson RL, Laws A, et al. 1994 A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose intolerance. Insulin Resistance Atherosclerosis Study. Diabetes. 43:1114-1121.
16. Ferrannini E. 1988 The theoretical bases of indirect calorimetry: a review. Metabolism. 37:287-301.
17. Heding LG. 1975 Specific and direct radioimmunoassay for human C-peptide in serum. Diabetologia. 11:547-548.
18. Heding LG. 1972 Determination of total serum insulin (IRI) in insulin treated diabetic patients. Diabetologia. 8:260-266.
19. Holst JJ. 1980 Evidence that glicentin contains the entire sequence of glucagon. Biochem J. 187:337-343.
20. 14C-glucose in pig plasma. Diabetologia. 32:660-662.
21. Ferrannini E, Del Prato S, DeFronzo RA. 1986 Glucose kinetics, tracer methods. In: Methods in diabetes research. New York: Wiley and Sons; vol 2:107-140.
22. Vølund Aa, Polonsky KS, Bergman RN. 1987 Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics. Diabetes. 36:1195-1202.
23. Christiansen E, Kjems L, Tibell A, Groth CG, Vølund Aa, Madsbad S. 1994 Estimation of insulin secretion rates based on individual C-peptide kinetic parameters in pancreas transplants. Diabetologia. 37(Suppl 1):A214.
24. Cobelli C, Mari A, Ferrannini E. 1987 Non-steady state: error analysis of Steele's model and development for glucose kinetics. Am J Physiol. 252:E679-E689.
25. Frayn KN. 1983 Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol. 55:628-634.
26. Pagano G, Cavallo-Perin P, Cassader M, et al. 1983 An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J Clin Invest. 72:1814-1820.
27. Yamamoto A, Akazawa S, Yamaguchi Y, et al. 1991 Effects of cyclosporin A and low dosages of steroid on posttransplant diabetes in kidney transplant recipients. Diabetes Care. 14:867-870.
28. Christiansen E, Tibell A, Groth CG, et al. 1994 Limitations in the use of insulin or C-peptide alone in the assessment of β-cell function in pancreas transplant recipients. Transplant Proc. 26:467-468.
29. Wilczek H, Gunnarsson R, Felig P, et al. 1991 Normalization of hepatic glucose production despite systemic insulin delivery. Studies in patients with pancreas transplantation for type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 34:345-349.
30. Christiansen E, Tibell A, Vølund Aa, et al. 1996 Pancreatic endocrine function in recipients of segmental and whole pancreas transplantation. J Clin Endocrinol Metab. 81:3972-3979.
31. Kahn SE, Prigeon RL, McCulloch DK, et al. 1993 Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 42:1663-1672.
32. Hother-Nielsen O, Vaag A, Skøtt P, Beck-Nielsen H. 1993 Effect of hyperglycemia per se on glucose turnover rates in patients with insulin-dependent diabetes. Metabolism. 42:86-93.
33. Rizza RA, Mandarino LJ, Gerich JE. 1982 Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor defect of insulin action. J Clin Endocrinol Metab. 54:131-138.
34. Boden G, Chen X, Ruiz J, et al. 1994 Insulin receptor down-regulation and impaired antilipolytic action of insulin in diabetic patients after pancreas/ kidney transplantation. J Clin Endocrinol Metab. 78:657-663.
35. Hanks J, McAloon-Dyke M, Clark B, et al. 1992 Insulin response, glucose homeostasis and Glut4 levels in muscle after pancreas transplant: comparison of initial study with one-year follow-up [Abstract]. Regul Peptides. 40:166.
36. Thorburn AW, Gumbiner B, Brechtel G, et al. 1990 Effect of hyperinsulinemia and hyperglycemia on intracellular glucose and fat metabolism in healthy subjects. Diabetes. 39:22-30.
37. Henry RR, Thorburn AW, Beerdsen P, et al. 1991 Dose-response characteristics of impaired glucose oxidation in non-insulin-dependent diabetes mellitus. Am J Physiol. 261:E132-E140.
38. Golay A, Defronzo RA, Ferrannini E, et al. 1988 Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 31:585-591.